<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" data-ismulti="true" isTestContent="false"><head xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table" xmlns:act="http://www.gov.bc.ca/2013/legislation/act" xmlns:reg="http://www.gov.bc.ca/2013/legislation/regulation" xmlns:bcl="http://www.gov.bc.ca/2013/bclegislation" xmlns:in="http://www.qp.gov.bc.ca/2013/inline" xmlns:xlink="http://www.w3.org/1999/xlink"><meta http-equiv="Content-Type" content="text/html; charset=UTF-8" /><META content="text/html; charset=utf-8" http-equiv="Content-Type"></META><META content="IE=edge" http-equiv="X-UA-Compatible"></META><title>Workers Compensation
    Act</title><link href="/standards/Acts.css" rel="stylesheet" type="text/css" /><script src="https://code.jquery.com/jquery-1.7.1.min.js" type="text/javascript"></script><script type="text/javascript">						function launchNewWindow(url)
						{
							window.open(url,'','toolbar=1,scrollbars=1,location=0,statusbar=1,menubar=1,resizable=1,');
						}
						
						window.onload = function() {
							document.body.style.display = "block";
						}
						</script><script type="text/javascript">
							function showhide(elem) {
								var div = elem.nextSibling;
								while (div.nodeType!=1) {
									div = div.nextSibling;
								}
								if (div.style.display == 'block') {
									div.style.display = 'none';
								} else {
									div.style.display = 'block';
								}	
							}
						</script><style type="text/css">
							span.container {
								position:relative;
							}
	
							span.box {
								display:none;
							}

							a:hover+span.box, span.box iframe:hover, span.box:hover {
								display:block;
								z-index:100;
								position:absolute;
								left:10px;
							}
							#toolBar {
								position:fixed;
								top:5px;
								left:0;
								width: 100%;
								height: 25px;
								padding: 5px 10px;
								border-bottom: 3px solid #333; /* some styling */
							}
						</style><style type="text/css" media="print">
							#contentsscroll{
							height: auto;
							overflow-y: auto;
							}
							#toolBar{
							display: none; 
							}
						</style><style type="text/css" media="screen">
							#contentsscroll{
							height: 90%;
							width: 98%;
							padding-left: 20px;
							margin-top: 40px;
							overflow: auto;
							}
							
							body {
							display: none;
							}
						</style></head><body xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table" xmlns:act="http://www.gov.bc.ca/2013/legislation/act" xmlns:reg="http://www.gov.bc.ca/2013/legislation/regulation" xmlns:bcl="http://www.gov.bc.ca/2013/bclegislation" xmlns:in="http://www.qp.gov.bc.ca/2013/inline" xmlns:xlink="http://www.w3.org/1999/xlink" bgcolor="#FFFFFF" text="#000000"><div xmlns="" xmlns:xs="http://www.w3.org/2001/XMLSchema" id="toolBar"><a id="searchHit" href="#">Search Results</a> | <a id="clearSearch" href="#">Clear Search</a> | <a id="prevHit" href="#">Previous (in doc)</a> | <a id="nextHit" href="#">Next (in doc)</a> | <a id="pdocHit" href="#">Prev Doc</a> | <a id="ndocHit" href="#">Next Doc</a></div><div id="contentsscroll"><div id="header"><table border="0" cellpadding="4" cellspacing="0" width="100%"><tr><td class="sizesmall" valign="bottom">Copyright © King's Printer,<br />						Victoria, British Columbia, Canada</td><td align="right" class="sizemedium"><a href="/standards/Licence.html"><strong>Licence</strong></a><br /><a href="/standards/Disclaimer.html" target="_blank"><strong>Disclaimer</strong></a></td></tr></table></div><p align="right" class="bold"><a href="/civix/document/id/complete/statreg/19001_00_multi">View Complete Statute</a></p><div id="act:currency"><table align="center" cellpadding="2" cellspacing="0"><tr><td class="currencysingle" colspan="4">											This Act is current to March 5, 2024</td></tr><tr><td class="tabletext" colspan="4">See the <a href="/civix/content/complete/statreg/901199259/1241438022/1820334683/?xsl=/templates/browse.xsl">Tables of Legislative Changes</a> for this Act’s legislative history, including any changes not in force.</td></tr></table></div><div id="title"><h2>Workers Compensation    Act</h2><h3>[RSBC 2019] CHAPTER
								1</h3><p align="right"><em>Deposited with Clerk of the Legislative Assembly on August 23, 2019</em></p><p align="center" field="repealedtext"><em>[Note: the dollar amounts shown in sections 94, 95, 102, 167, 169, 170
    to 175, 191, 194, 208, 213, 225, 231, 236, 251 and 349 may not reflect the current consumer
    price index adjustments referred to in section 333, and the maximum wage rate shown in section
    209 (2) and 227 may not be current.</em><br /><br /><em>Current information may be
    found on the Workers' Compensation Board website at
    www.worksafebc.com/en/law-policy/claims-rehabilitation/claims-related-consumer-price-index or
    may be obtained by calling your WorkSafeBC regional office.]</em></p></div><p align="center" class="bold"><a name="Schedule1"></a>Schedule 1</p><p class="scheduleSubTitle"> Presumption of Occupational Disease Related to Specific Process or
        Industry</p><table align="center" cellSpacing="0" cellPadding="3" border="1" class="tablestyle2"><tr><td valign="top" align="center">Item</td><td valign="top" align="left">Column 1<br /><strong> Description of
                  Disease</strong></td><td valign="top" align="left">Column 2<br /><strong> Description of Process or
                  Industry</strong></td></tr><tbody><tr><td valign="top" align="center" rowspan="14">1</td><td valign="top" align="left">Poisoning by:</td><td valign="top" align="left"> </td></tr><tr><td valign="top" align="left">(1) Lead</td><td valign="top" align="left">Where there is exposure to lead or lead compounds.</td></tr><tr><td valign="top" align="left">(2) Mercury</td><td valign="top" align="left">Where there is exposure to mercury or mercury compounds.</td></tr><tr><td valign="top" align="left">(3) Arsenic or arsine</td><td valign="top" align="left">Where there is exposure to arsenic or arsenic compounds.</td></tr><tr><td valign="top" align="left">(4) Cadmium</td><td valign="top" align="left">Where there is exposure to cadmium or cadmium compounds.</td></tr><tr><td valign="top" align="left">(5) Manganese</td><td valign="top" align="left">Where there is exposure to manganese or manganese
                  compounds.</td></tr><tr><td valign="top" align="left">(6) Phosphorus, phosphine or the anti-cholinesterase action of organic
                  phosphorus compounds</td><td valign="top" align="left">Where there is exposure to phosphorus or phosphorus
                  compounds.</td></tr><tr><td valign="top" align="left">(7) Organic solvents, including n-hexane, carbon tetrachloride,
                  trichloroethane, trichloroethylene, acetone, benzene, toluene and
                  xylene</td><td valign="top" align="left">Where there is exposure to organic solvents.</td></tr><tr><td valign="top" align="left">(8) Carbon monoxide</td><td valign="top" align="left">Where there is exposure to products of combustion or to any other source
                  of carbon monoxide.</td></tr><tr><td valign="top" align="left">(9) Hydrogen sulphide</td><td valign="top" align="left">Where there is excessive exposure to hydrogen sulphide.</td></tr><tr><td valign="top" align="left">(10) Nitrous fumes, including silo-filler's disease</td><td valign="top" align="left">Where there is excessive exposure to nitrous fumes, including the oxides
                  of nitrogen.</td></tr><tr><td valign="top" align="left">(11) Nitriles, hydrogen cyanide or its soluble salts</td><td valign="top" align="left">Where there is exposure to chemicals containing -CN group, including
                  certain pesticides.</td></tr><tr><td valign="top" align="left">(12) Phosgene</td><td valign="top" align="left">Where there is excessive exposure to phosgene, including its occurrence
                  as a breakdown product of chlorinated compounds by combustion.</td></tr><tr><td valign="top" align="left">(13) Other toxic substances</td><td valign="top" align="left">Where there is exposure to such toxic gases, vapours, mists, fumes or
                  dusts.</td></tr><tr><td valign="top" align="center" rowspan="5">2</td><td valign="top" align="left">Infection caused by:</td><td valign="top" align="left"></td></tr><tr><td valign="top" align="left">(1) Psittacosis virus</td><td valign="top" align="left">Where there is established contact with ornithosis-infected avian
                  species or material.</td></tr><tr><td valign="top" align="left">(2) Salmonella organisms, Staphylococcus aureus, or Hepatitis B
                  virus</td><td valign="top" align="left"> Where close and frequent contact with a source or sources of the
                  infection has been established and the employment necessitates<br /><table cellSpacing="0" cellPadding="3" class="tablestyle3"><tbody><tr><td align="left" valign="top">(a)</td><td align="left" valign="top">the treatment, nursing or examination of or interviews with
                            patients or ill persons,</td></tr><tr><td align="left" valign="top">(b)</td><td align="left" valign="top">the analysis or testing of body tissues or fluids,
                            or</td></tr><tr><td align="left" valign="top">(c)</td><td align="left" valign="top">research into salmonellae, pathogenic staphylococci or
                            Hepatitis B virus.</td></tr></tbody></table></td></tr><tr><td valign="top" align="left">(3) Brucella organisms, including Undulant fever</td><td valign="top" align="left">Where there is contact with animals, animal carcasses or animal
                  by-products.</td></tr><tr><td valign="top" align="left">(4) Tubercle bacillus</td><td valign="top" align="left">Where close and frequent contact with a source or sources of tuberculous
                  infection has been established and the employment necessitates<br /><table cellSpacing="0" cellPadding="3" class="tablestyle3"><tbody><tr><td align="left" valign="top">(a)</td><td align="left" valign="top" colspan="2">the treatment, nursing or examination of patients or ill
                            persons,</td></tr><tr><td align="left" valign="top">(b)</td><td align="left" valign="top" colspan="2">the analysis or testing of body tissues or fluids,
                            or</td></tr><tr><td align="left" valign="top">(c)</td><td align="left" valign="top" colspan="2">research into tuberculosis by a worker who,</td></tr><tr><td align="left" valign="top"> </td><td align="left" valign="top">(i)</td><td align="left" valign="top">when first engaged, or after an absence from employment of the
                            types mentioned in these regulations for a period of more than one year,
                            when re-engaged in such employment was free from evidence of
                            tuberculosis, and</td></tr><tr><td align="left" valign="top"> </td><td align="left" valign="top">(ii)</td><td align="left" valign="top">continued to be free from evidence of tuberculosis for 6
                            months after being so employed, except in the case of primary
                            tuberculosis as proven by a negative tuberculin test at the time of
                            employment. In the case of a worker previously compensated for
                            tuberculosis, any subsequent tuberculosis after the disease has become
                            inactive and has remained inactive for a period of 3 years or more is
                            not to be considered to have occurred as a result of the original
                            disability, unless the worker is still engaged in employment listed
                            above or the Board is satisfied that the subsequent tuberculosis is the
                            direct result of the tuberculosis for which the worker has been
                            compensated.</td></tr></tbody></table></td></tr><tr><td valign="top" align="center" rowspan="4">3</td><td valign="top" align="left">Pneumoconiosis:</td><td valign="top" align="left"></td></tr><tr><td valign="top" align="left">(1) Silicosis</td><td valign="top" align="left">Where there is exposure to airborne silica dust, including in
                  metalliferous mining and coal mining.</td></tr><tr><td valign="top" align="left">(2) Asbestosis</td><td valign="top" align="left">Where there is exposure to airborne asbestos dust.</td></tr><tr><td valign="top" align="left">(3) Other pneumoconioses</td><td valign="top" align="left">Where there is exposure to the airborne dusts of coal, beryllium,
                  tungsten carbide, aluminum or other dusts known to produce fibrosis of the
                  lungs.</td></tr><tr><td valign="top" align="center">4</td><td valign="top" align="left">Diffuse pleural thickening or fibrosis, whether unilateral or
                  bilateral</td><td valign="top" align="left">Where there is exposure to airborne asbestos dust and the worker has not
                  previously had and does not currently have collagen disease, chronic uremia,
                  drug-induced fibrosis, tuberculosis or other infection, trauma or disease capable
                  of causing pleural thickening or fibrosis.</td></tr><tr><td valign="top" align="center">5</td><td valign="top" align="left">Benign pleural effusion, whether unilateral or bilateral</td><td valign="top" align="left">Where there is exposure to airborne asbestos dust and the worker has not
                  previously had and does not currently have collagen disease, chronic uremia,
                  tuberculosis or other infection, trauma or disease capable of causing pleural
                  effusion.</td></tr><tr><td valign="top" align="center" rowspan="13">6</td><td valign="top" align="left">Cancer:</td><td valign="top" align="left"></td></tr><tr><td valign="top" align="left">(1) Primary carcinoma of the lung when associated with
                  asbestosis</td><td valign="top" align="left">Where there is exposure to airborne asbestos dust.</td></tr><tr><td valign="top" align="left">(2) Primary carcinoma of the lung when associated with bilateral diffuse
                  pleural thickening over 2 mm thick</td><td valign="top" align="left">Where there is exposure to airborne asbestos dust and the worker has not
                  previously had collagen disease, chronic uremia, drug-induced fibrosis,
                  tuberculosis or other infection or trauma capable of causing pleural
                  thickening.</td></tr><tr><td valign="top" align="left">(3) Primary carcinoma of the lung</td><td valign="top" align="left"> Where there is exposure to airborne asbestos dust for a period of 10
                  years or more of employment in one or more of the following
                  industries:<br /><table cellSpacing="0" cellPadding="3" class="tablestyle3"><tbody><tr><td align="left" valign="top">(a)</td><td align="left" valign="top">asbestos mining;</td></tr><tr><td align="left" valign="top">(b)</td><td align="left" valign="top">insulation or filter material production;</td></tr><tr><td align="left" valign="top">(c)</td><td align="left" valign="top">construction, where there is disturbance of
                            asbestos-containing materials;</td></tr><tr><td align="left" valign="top">(d)</td><td align="left" valign="top">plumbing or electrical work;</td></tr><tr><td align="left" valign="top">(e)</td><td align="left" valign="top">pulp mill work;</td></tr><tr><td align="left" valign="top">(f)</td><td align="left" valign="top">shipyard work;</td></tr><tr><td align="left" valign="top">(g)</td><td align="left" valign="top">longshoring.</td></tr></tbody></table></td></tr><tr><td valign="top" align="left">(4) Mesothelioma, whether pleural or peritoneal</td><td valign="top" align="left">Where there is exposure to airborne asbestos dust.</td></tr><tr><td valign="top" align="left">(5) Carcinoma, associated with asbestosis, of the larynx or
                  pharynx</td><td valign="top" align="left">Where there is exposure to airborne asbestos dust.</td></tr><tr><td valign="top" align="left">(6) Gastrointestinal cancer, including all primary cancers associated
                  with the esophagus, stomach, small bowel, colon and rectum excluding the anus, and
                  without regard to the site of the cancer in the gastrointestinal tract or the
                  histological structure of the cancer</td><td valign="top" align="left">Where there is exposure to asbestos dust if, during the period between
                  the first exposure to asbestos dust and the diagnosis of gastrointestinal cancer,
                  there has been a period of, or periods adding up to, 20 years of continuous
                  exposure to asbestos dust and such exposure represents or is a manifestation of
                  the major component of the occupational activity in which the exposure
                  occurred.</td></tr><tr><td valign="top" align="left">(7) Primary cancer of the lung</td><td valign="top" align="left"> Where there is prolonged exposure to any of the
                  following:<br /><table cellSpacing="0" cellPadding="3" class="tablestyle3"><tbody><tr><td align="left" valign="top">(a)</td><td align="left" valign="top">aerosols and gases containing arsenic, chromium, nickel or
                            their compounds;</td></tr><tr><td align="left" valign="top">(b)</td><td align="left" valign="top">bis(chloromethyl) ether;</td></tr><tr><td align="left" valign="top">(c)</td><td align="left" valign="top">the dust of uranium, or radon gas and its decay
                            products;</td></tr><tr><td align="left" valign="top">(d)</td><td align="left" valign="top">particulate polycyclic aromatic hydrocarbons.</td></tr></tbody></table></td></tr><tr><td valign="top" align="left">(8) Leukemia or pre-leukemia</td><td valign="top" align="left">Where there is prolonged exposure to benzene or to ionizing
                  radiation.</td></tr><tr><td valign="top" align="left">(9) Primary cancer of the skin</td><td valign="top" align="left">Where there is<br /><table cellSpacing="0" cellPadding="3" class="tablestyle3"><tbody><tr><td align="left" valign="top">(a)</td><td align="left" valign="top">prolonged contact with coal tar products, arsenic or cutting
                            oils, or</td></tr><tr><td align="left" valign="top">(b)</td><td align="left" valign="top">prolonged exposure to solar ultraviolet light.</td></tr></tbody></table></td></tr><tr><td valign="top" align="left">(10) Primary cancer of the epithelial lining of the urinary bladder,
                  ureter or renal pelvis</td><td valign="top" align="left">Where there is prolonged exposure to beta-naphthylamine, benzidine or
                  4-nitrodiphenyl.</td></tr><tr><td valign="top" align="left">(11) Primary cancer of the mucous lining of the nose or nasal
                  sinuses</td><td valign="top" align="left">Where there is prolonged exposure to<br /><table cellSpacing="0" cellPadding="3" class="tablestyle3"><tbody><tr><td align="left" valign="top">(a)</td><td align="left" valign="top">dusts, fumes or mists containing nickel, or</td></tr><tr><td align="left" valign="top">(b)</td><td align="left" valign="top">the dusts of hard woods.</td></tr></tbody></table></td></tr><tr><td valign="top" align="left">(12) Angiosarcoma of the liver</td><td valign="top" align="left">Where there is exposure to vinyl chloride monomer.</td></tr><tr><td valign="top" align="center">7</td><td valign="top" align="left">Asthma</td><td valign="top" align="left"> Where there is exposure to any of the following:<br /><table cellSpacing="0" cellPadding="3" class="tablestyle3"><tbody><tr><td align="left" valign="top">(a)</td><td align="left" valign="top">western red cedar dust;</td></tr><tr><td align="left" valign="top">(b)</td><td align="left" valign="top">isocyanate vapours or gases;</td></tr><tr><td align="left" valign="top">(c)</td><td align="left" valign="top">the dusts, fumes or vapours of other chemicals or organic
                            material known to cause asthma.</td></tr></tbody></table></td></tr><tr><td valign="top" align="center">8</td><td valign="top" align="left">Extrinsic allergic alveolitis, including farmers' lung and mushroom
                  workers' lung</td><td valign="top" align="left">Where there is repeated exposure to respirable organic
                  dusts.</td></tr><tr><td valign="top" align="center">9</td><td valign="top" align="left">Acute upper respiratory inflammation, acute pharyngitis, acute
                  laryngitis, acute tracheitis, acute bronchitis, acute pneumonitis or acute
                  pulmonary edema, excluding any allergic reaction, reaction to environmental
                  tobacco smoke or effect of an infection</td><td valign="top" align="left">Where<br /><table cellSpacing="0" cellPadding="3" class="tablestyle3"><tbody><tr><td align="left" valign="top">(a)</td><td align="left" valign="top">there is exposure to a high concentration of fumes, vapours,
                            gases, mists or dusts of substances that have irritating or inflammatory
                            properties, and</td></tr><tr><td align="left" valign="top">(b)</td><td align="left" valign="top">the respiratory symptoms occur within 48 hours of the exposure
                            or, if there is exposure to nitrogen dioxide or phosgene, within 72
                            hours of the exposure.</td></tr></tbody></table></td></tr><tr><td valign="top" align="center">10</td><td valign="top" align="left">Metal fume fever</td><td valign="top" align="left">Where there is exposure to the fumes of zinc or other
                  metals.</td></tr><tr><td valign="top" align="center">11</td><td valign="top" align="left">Fluorosis</td><td valign="top" align="left">Where there is exposure to high concentrations of fluorine or fluorine
                  compounds, whether in gaseous or particulate form.</td></tr><tr><td valign="top" align="center">12</td><td valign="top" align="left">Neurosensory hearing loss</td><td valign="top" align="left">Where there is prolonged exposure to excessive noise
                  levels.</td></tr><tr><td valign="top" align="center" rowspan="3">13</td><td valign="top" align="left">Bursitis:</td><td valign="top" align="left"></td></tr><tr><td valign="top" align="left">(1) Knee bursitis (inflammation of the prepatellar, suprapatellar or
                  superficial infrapatellar bursa)</td><td valign="top" align="left"> Where<br /><table cellSpacing="0" cellPadding="3" class="tablestyle3"><tbody><tr><td align="left" valign="top">(a)</td><td align="left" valign="top">there is repeated jarring impact against the involved bursa,
                            or</td></tr><tr><td align="left" valign="top">(b)</td><td align="left" valign="top">there are significant periods of kneeling on the involved
                            bursa.</td></tr></tbody></table></td></tr><tr><td valign="top" align="left">(2) Shoulder bursitis (inflammation of the subacromial or subdeltoid
                  bursa)</td><td valign="top" align="left">Where there is frequently repeated or sustained abduction or flexion of
                  the shoulder joint greater than 60° and where such activity represents a
                  significant component of the employment.</td></tr><tr><td valign="top" align="center" rowspan="3">14</td><td valign="top" align="left">Tendinopathy:</td><td valign="top" align="left"></td></tr><tr><td valign="top" align="left">(1) Hand-wrist tendinopathy</td><td valign="top" align="left">Where there is use of the affected tendon or tendons to perform a task
                  or series of tasks that involve any 2 of the following and where such activity
                  represents a significant component of the employment:<br /><table cellSpacing="0" cellPadding="3" class="tablestyle3"><tbody><tr><td align="left" valign="top">(a)</td><td align="left" valign="top">frequently repeated motions or muscle contractions that place
                            strain on the affected tendon or tendons;</td></tr><tr><td align="left" valign="top">(b)</td><td align="left" valign="top">significant flexion, extension, ulnar deviation or radial
                            deviation of the affected hand or wrist;</td></tr><tr><td align="left" valign="top">(c)</td><td align="left" valign="top">forceful exertion of the muscles used in handling or moving
                            tools or other objects with the affected hand or wrist.</td></tr></tbody></table></td></tr><tr><td valign="top" align="left">(2) Shoulder tendinopathy</td><td valign="top" align="left">Where there is frequently repeated or sustained abduction or flexion of
                  the shoulder joint greater than 60° and where such activity represents a
                  significant component of the employment.</td></tr><tr><td valign="top" align="center">15</td><td valign="top" align="left">Decompression sickness</td><td valign="top" align="left">Where there is exposure to increased air pressure.</td></tr><tr><td valign="top" align="center">16</td><td valign="top" align="left">Contact dermatitis</td><td valign="top" align="left">Where there is excessive exposure to irritants, allergens or sensitizers
                  ordinarily causative of dermatitis.</td></tr><tr><td valign="top" align="center">17</td><td valign="top" align="left">Hand-arm vibration syndrome</td><td valign="top" align="left">Where there has been at least 1 000 hours of exposure to tools or
                  equipment that causes the transfer of significant vibration to the hand or arm of
                  the worker.</td></tr><tr><td valign="top" align="center" rowspan="5">18</td><td valign="top" align="left">Radiation injury or disease:</td><td valign="top" align="left"></td></tr><tr><td valign="top" align="left">(1) Due to ionizing radiation</td><td valign="top" align="left">Where there is exposure to ionizing radiation.</td></tr><tr><td valign="top" align="left">(2) Due to non-ionizing radiation:</td><td valign="top" align="left"></td></tr><tr><td valign="top" align="left">  (a) conjunctivitis or keratitis</td><td valign="top" align="left">Where there is exposure to ultraviolet light.</td></tr><tr><td valign="top" align="left">  (b) cataract or other thermal damage to the eye</td><td valign="top" align="left">Where there is excessive exposure to infrared, microwave or laser
                  radiation.</td></tr><tr><td valign="top" align="center">19</td><td valign="top" align="left">Erosion of incisor teeth</td><td valign="top" align="left">Where there is exposure to acid fumes or mist.</td></tr><tr><td valign="top" align="center" rowspan="3">20</td><td valign="top" align="left">Infection that is</td><td valign="top" align="left" rowspan="3">Where<br />  (a) there is a risk of exposure to a source or sources of
                  infection significantly greater than that to the public at large,<br />  (b) the
                  risk of exposure occurs during the applicable notice or emergency under column 1,
                  and<br />  (c) the risk of exposure occurs within the geographical area of the
                  applicable notice or emergency under column 1.</td></tr><tr><td valign="top" align="left">(1) caused by communicable viral pathogens, and</td></tr><tr><td valign="top" align="left">(2) the subject of one or more of the following:<br />  (a) notice
                  given under section 52 (2) of the <em>Public Health Act</em>;<br />  (b)
                  a state of emergency declared under section 9 (1) of the <em>Emergency Program
                  Act</em>;<br />  (c) a state of local emergency declared under section 12
                  (1) of the <em>Emergency Program Act</em>;<br />  (d) an emergency
                  declared under section 173 of the <em>Vancouver Charter</em>.</td></tr></tbody></table><p align="center" class="bold"><a name="Schedule2"></a> Schedule 2</p><p class="scheduleSubTitle">Non-Traumatic Hearing Loss</p><div class="section"><a name="section1"></a><h4><a name="section1"></a>Interpretation of table</h4><p id="d1e24420" class="sec nosubsecnum"><span class="secnum"><span class="secnumholder"><b>1</b>
		  </span></span>In the table in this Schedule,</p><p class="para"><a name="d1e24429"></a><span class="num"><span class="holder">(a)</span></span> a range of decibels set out in column 1 reflects hearing loss measured in
            accordance with section 2 of this Schedule,</p><p class="para"><a name="d1e24435"></a><span class="num"><span class="holder">(b)</span></span> a percentage of disability set out in column 2 opposite a range of decibels set
            out in column 1 is the percentage of disability for the ear most affected by the hearing
            loss, and</p><p class="para"><a name="d1e24443"></a><span class="num"><span class="holder">(c)</span></span> a percentage of disability set out in column 3 opposite a range of decibels set
            out in column 1 is the percentage of disability for the ear least affected by the
            hearing loss.</p></div><div class="section"><a name="section2"></a><h4><a name="section2"></a>Measuring hearing loss</h4><p id="d1e24451" class="sec "><span class="secnum"><span class="secnumholder"><b>2</b>
		  <a name="d1e24457"></a>(1) </span></span>Loss of hearing is measured</p><p class="para"><a name="d1e24463"></a><span class="num"><span class="holder">(a)</span></span> by calculating the average of the threshold of hearing in each ear measured at
              the frequencies of 1 000, 2 000, 3 000 and 4 000 Hertz, in turn, by pure-tone air- or
              bone-conduction audiometry, and</p><p class="para"><a name="d1e24470"></a><span class="num"><span class="holder">(b)</span></span> using an audiometer calibrated by a facility that meets the requirements
              established by the Board.</p><p class="sub"><a name="d1e24478"></a><span class="num"><span class="holder">(2) </span></span>For the purposes of section 198 (2) of this Act, a loss of hearing in the range
            of decibels set out in column 1 of item 11 of the table in this Schedule constitutes a
            complete loss of hearing.</p></div><div class="section"><a name="section3"></a><h4><a name="section3"></a>Percentage of total disability</h4><p id="d1e24486" class="sec nosubsecnum"><span class="secnum"><span class="secnumholder"><b>3</b>
		  </span></span>For the purposes of section 198 of this Act,</p><p class="para"><a name="d1e24494"></a><span class="num"><span class="holder">(a)</span></span> the percentage of total disability is the sum of the percentage of disability
            for the ear most affected by the hearing loss and the percentage of disability for the
            ear least affected by the hearing loss,</p><p class="para"><a name="d1e24501"></a><span class="num"><span class="holder">(b)</span></span> the maximum percentage of total disability for a complete loss of hearing in one
            ear and no loss of hearing in the other ear is 6%, and</p><p class="para"><a name="d1e24509"></a><span class="num"><span class="holder">(c)</span></span> the maximum percentage of total disability for a complete loss of hearing in
            both ears is 36%.</p></div><p align="center"><strong>TABLE</strong></p><table align="center" cellSpacing="0" cellPadding="3" border="1" class="tablestyle2"><tr><td valign="top" align="center">Item</td><td valign="top" align="center">Column 1<br /><strong>Range of Hearing Loss
                  (decibels)</strong></td><td valign="top" align="center">Column 2<br /><strong>Percentage of Disability for Ear Most
                  Affected</strong></td><td valign="top" align="center">Column 3<br /><strong>Percentage of Disability for Ear Least
                  Affected</strong></td></tr><tbody><tr><td valign="top" align="center">1</td><td valign="top" align="center">0-34</td><td valign="top" align="center">0</td><td valign="top" align="center">0</td></tr><tr><td valign="top" align="center">2</td><td valign="top" align="center">35-39</td><td valign="top" align="center">0.3</td><td valign="top" align="center">1.5</td></tr><tr><td valign="top" align="center">3</td><td valign="top" align="center">40-44</td><td valign="top" align="center">1.0</td><td valign="top" align="center">5.0</td></tr><tr><td valign="top" align="center">4</td><td valign="top" align="center">45-49</td><td valign="top" align="center">1.7</td><td valign="top" align="center">8.5</td></tr><tr><td valign="top" align="center">5</td><td valign="top" align="center">50-54</td><td valign="top" align="center">2.3</td><td valign="top" align="center">11.5</td></tr><tr><td valign="top" align="center">6</td><td valign="top" align="center">55-59</td><td valign="top" align="center">3.0</td><td valign="top" align="center">15.0</td></tr><tr><td valign="top" align="center">7</td><td valign="top" align="center">60-64</td><td valign="top" align="center">3.7</td><td valign="top" align="center">18.5</td></tr><tr><td valign="top" align="center">8</td><td valign="top" align="center">65-69</td><td valign="top" align="center">4.3</td><td valign="top" align="center">21.5</td></tr><tr><td valign="top" align="center">9</td><td valign="top" align="center">70-74</td><td valign="top" align="center">5.0</td><td valign="top" align="center">25.0</td></tr><tr><td valign="top" align="center">10</td><td valign="top" align="center">75-79</td><td valign="top" align="center">5.7</td><td valign="top" align="center">28.5</td></tr><tr><td valign="top" align="center">11</td><td valign="top" align="center">80 or more</td><td valign="top" align="center">6.0</td><td valign="top" align="center">30.0</td></tr></tbody></table><p align="center"><strong><a href="/civix/document/id/complete/statreg/19001_00">Contents</a> 				| </strong><strong><a href="/civix/document/id/complete/statreg/19001_01">Part 1</a> 				| </strong><strong><a href="/civix/document/id/complete/statreg/19001_02">Part 2</a> 				| </strong><strong><a href="/civix/document/id/complete/statreg/19001_03">Part 3</a> 				| </strong><strong><a href="/civix/document/id/complete/statreg/19001_04">Part 4</a> 				| </strong><strong><a href="/civix/document/id/complete/statreg/19001_05">Part 5</a> 				| </strong><strong><a href="/civix/document/id/complete/statreg/19001_06">Part 6</a> 				| </strong><strong><a href="/civix/document/id/complete/statreg/19001_07">Part 7</a> 				| </strong><strong><a href="/civix/document/id/complete/statreg/19001_08">Part 8</a> 				| </strong><strong>Schedules 
				| </strong><strong><a href="/civix/document/id/complete/statreg/19001_10">Revision Schedules</a> 				| </strong><strong><a href="/civix/document/id/complete/statreg/19001_11">Consumer Price Index Adjustments</a></strong></p><p class="copyright">Copyright © King's Printer, Victoria, British							Columbia, Canada</p></div></body></html>
